Illuminated Chopper in Cataract Surgery (IChopper)
Prospective Randomized, Paired-Eye, Comparative Study Between Cataract Surgeries With and Without an Illuminated Chopper
This study compares cataract surgery performed with an illuminated chopper and intracameral illumination with cataract surgery performed under conventional external coaxial microscope illumination. Participants undergoing bilateral cataract surgery will have one eye treated with the illuminated chopper and the other eye treated without the illuminated chopper, with the order randomized between eyes.
The study will evaluate differences in operation time, pupil size, the need for additional intraocular medications or devices, intraoperative and postoperative complications, and postoperative clinical outcomes including visual acuity and intraocular pressure.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
This is a prospective, randomized, paired-eye comparative clinical study in participants undergoing bilateral cataract surgery. Each participant will undergo cataract surgery in both eyes. One eye will be treated using the iChopper illumination chopper with the iVision light source, while the fellow eye will undergo cataract surgery using conventional external coaxial microscope illumination. The order of the surgical method between the right and left eyes will be randomized.
The illuminated chopper provides intracameral illumination during cataract surgery and is designed to improve visualization of intraocular structures while also functioning as a lens chopper. The investigational device has received U.S. FDA 510(k) clearance.
The study will assess intraoperative outcomes including operation time, pupil size, ultrasound usage time, pupil-related surgical difficulties, intraoperative complications, and the use of additional intraocular medications or devices. Postoperative assessments will include visual acuity, manifest refraction, intraocular pressure, and postoperative complications.
Participants will undergo bilateral cataract surgery with the two procedures scheduled approximately 1 to 3 weeks apart. Follow-up assessments will be performed approximately 1 day and 30 days after surgery for each eye.
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Florida
-
Cape Coral, Florida, Vereinigte Staaten, 33904
- Tyson Eye
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age 40 years or older
- Diagnosis of bilateral cataract
- Both eyes suitable for cataract surgery
- Expected postoperative best-corrected visual acuity of 0.2 Snellen or better
- No other secondary ocular surgeries planned during the study period
- Ability to comply with all study procedures and follow-up visits
- Ability and willingness to provide written informed consent
Exclusion Criteria:
- Preoperative ocular or systemic conditions, or medication use, that may affect study outcomes, increase risk to the participant, or predispose to complications, including infectious disease, ocular atrophy, or zonular weakness
- Poorly controlled diabetes mellitus
- Use of alpha-blockers such as tamsulosin for benign prostatic hyperplasia
- Planned femtosecond laser-assisted cataract surgery
- Congenital ocular disorders
- History of ophthalmic surgery in either eye that may affect study outcomes or increase risk, including retinal surgery, glaucoma surgery, or anterior segment surgery
- Inability to provide informed consent
- Pregnancy
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Illuminated Chopper in Right Eye
Participants assigned to this arm undergo cataract surgery using the illuminated chopper in the right eye and cataract surgery under conventional external coaxial microscope illumination in the left eye. |
Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification. Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper. |
|
Experimental: Illuminated Chopper in Left Eye
Participants assigned to this arm undergo cataract surgery under conventional external coaxial microscope illumination in the right eye and cataract surgery using the illuminated chopper in the left eye. |
Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification. Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Operation Time
Zeitfenster: During cataract surgery
|
Operation time during cataract surgery will be recorded and compared between eyes undergoing surgery with the illuminated chopper and eyes undergoing surgery with conventional microscope illumination. |
During cataract surgery
|
|
Pupil Size During Cataract Surgery
Zeitfenster: During cataract surgery
|
Pupil size during cataract surgery will be assessed and compared between the illuminated chopper and conventional microscope illumination conditions. |
During cataract surgery
|
|
Use of Additional Intraocular Medications
Zeitfenster: During cataract surgery
|
The use of additional intraocular medications during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions. |
During cataract surgery
|
|
Use of Additional Intraocular Devices
Zeitfenster: During cataract surgery
|
The use of additional intraocular devices during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions. |
During cataract surgery
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Intraoperative Complications
Zeitfenster: During cataract surgery
|
Intraoperative complications occurring during cataract surgery, including pupil-related and other surgical complications, will be recorded and compared between the two surgical conditions. |
During cataract surgery
|
|
Postoperative Complications
Zeitfenster: From surgery through approximately 30 days after surgery
|
Postoperative complications following cataract surgery will be recorded and compared between eyes treated with and without the illuminated chopper. |
From surgery through approximately 30 days after surgery
|
|
Postoperative Distance Visual Acuity
Zeitfenster: Day 1 and Day 30 after surgery
|
Distance visual acuity will be assessed after cataract surgery and compared between the illuminated chopper and conventional microscope illumination conditions. |
Day 1 and Day 30 after surgery
|
|
Postoperative Intraocular Pressure
Zeitfenster: Day 1 and Day 30 after surgery
|
Intraocular pressure will be assessed during postoperative follow-up and compared between the illuminated chopper and conventional microscope illumination conditions. |
Day 1 and Day 30 after surgery
|
Andere Ergebnismessungen
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Incidence of Adverse Events
Zeitfenster: From surgery through approximately 30 days after surgery
|
The incidence of adverse events following cataract surgery will be assessed, including cystoid macular edema, endophthalmitis, lens luxation, pupillary block, retinal detachment, and persistent elevation of intraocular pressure requiring treatment. |
From surgery through approximately 30 days after surgery
|
|
Incidence of Postoperative Ocular Complications
Zeitfenster: From surgery through approximately 30 days after surgery
|
Ocular complications will be assessed, including flat anterior chamber, vitreous in the anterior chamber, residual lens material, intraocular lens decentration or tilt, posterior capsular fibrosis or opacity, and intraocular pressure elevation requiring treatment. |
From surgery through approximately 30 days after surgery
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Studienleiter: Dong Heun Nam, MD, PhD, Gachon University Gil Medical Center, College of Medicine, Incheon, Republic of Korea
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- OCL-IIC-01
- RS-2022-00141533 (Andere Zuschuss-/Finanzierungsnummer: The Korean government (the Ministry of Science and ICT; the Ministry of Trade, Industry, and Energy))
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
De-identified individual participant data may be shared with qualified researchers upon reasonable request after publication, subject to review by the study investigators and sponsor and in accordance with applicable ethical, privacy, and regulatory requirements.
IPD-Sharing-Zeitrahmen
Beginning after publication of the primary study results and available for 5 years thereafter.
IPD-Sharing-Zugriffskriterien
Data will be made available to qualified researchers who submit a reasonable and scientifically sound request. Requests will be reviewed by the study investigators and sponsor. Access will be provided for approved research purposes, subject to appropriate data use agreements and compliance with applicable ethical, privacy, and regulatory requirements.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .